Orchard Therapeutics Receives EC Approval for Treatment of Early-Onset Metachromatic Leukodystrophy

Data suggest gene, cell therapy trial initiations in Europe lag behind America — here's why

TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval

FDA Approves Spark Therapeutics’ LUXTURNA™ (voretigene neparvovec-rzyl)